KLF3 and pancreatic adenocarcinoma: Figure S2C shows that high KLF3 expression was associated with poorer PFI in ACC, LGG, GBMLGG, UVM, and PAAD, whereas better in KIRC, KIPAN, and HNSC. Furthermore, the expression level of KLF3 was positively correlated with poorer DFI in PAAD and ACC (Figure S2D). Taken together, the results suggest that KLF3 can effectively predict the prognosis of multiple cancers, most notably in PAAD.